SNYSanofiSigning up patients
A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
Gastric Cancer · Oesophageal Carcinoma
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 30 (planned)
- Started
- Jul 1, 2026
- Main results expected
- Aug 2, 2028
- Fully finished
- Aug 2, 2028
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Objective response rate
Measured over: From baseline to the end of study, up to approximately 2 years
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07692204 · record last updated 2026-07-20 · checked 2026-11-09 15:47 UTC